Daily News Podcast
Medicare Advantage pushback
The opioid epidemic is driving down the life expectancy in the U.S.
We have updated our Privacy Policy. Please take the time to review
From the Vascular Community
In Memoriam: Dr. John Ochsner
Dr. Ochsner, a world-renowned heart surgeon, will be remembered as a charismatic and skilled surgeon, a dedicated teacher, a loving father, and a...
From the Editor
I want you to do my job
There are problems ahead for all vascular surgeons, and my hope is to use this forum to unite us.
News from the SVS
Get up to Speed with VESAP4
News
Doctors decry inaction on physician-focused APMs
So far, PTAC has sent at least 10 APMs to the CMS. To date, not a single one has been approved or even tested on a limited scale.
Feature
Some doctors are warming to single-payer medicine
A “youth uprising” in support of a single-payer health care system at this year’s AMA House of Delegates meeting speaks to a cultural shift in the...
News from the SVS
Help Develop 3 SVS Guidelines
News from the SVS
Submit Ideas for VAM 2019
Feature
To tame prescription prices, HHS dips a toe into drug importation stream
Drug prices in the United States have continued to rise and more than 80% of Americans say the government should take action.
Daily News Podcast
Valsartan cancer risk is low
People with HIV develop more frailty even with treatment
News
CMS to resume risk adjustment payments for 2017
The program uses statewide average premiums to draw money from health insurance plans with few high-need patients and funnels it to those with...
From the Editor
Endofill and the 'Last Editorial'
Dr. Samson bids his fond farewell as medical editor.
News from the SVS
Revisit VAM in Photos, Print and More; VAM on Demand Available Soon
News from the SVS
Research Career Development Travel Award Deadline is Aug. 15
News
CMS proposes site-neutral payments for hospital outpatient setting
Site-neutral payments could save the government – and patients – money on every visit.
Conference Coverage
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
Clinicians are calling blood pressure drugs the first disease-modifying therapy for MCI.
News from the SVS
International Scholars Program Applications Due Aug. 2
Daily News Podcast
Brain damage, slight benefit seen in epinephrine cardiac arrest
SGLT2 inhibitors, including dapagliflozin, appear to have a beneficial class effect.
From the Journals
Nearly one-quarter of presurgery patients already using opioids
Surgical patients should be asked about their opioid use and pain history.
Residents' News
-
-
-
-
-
-
-
Vascular: The Final Frontier - Pushing vascular science where no science has gone before -
-
-
Commentary
-
-
-
-
-
Shinal v. Toms: It’s Now Harder to Get Informed Consent -
Letters to the Editor: 'Endo hubris' - We got letters -
Mitigating Burnout - Part 3 -
Special Report II: Tackling Burnout -
-
